Mediclarum

ATC MMusculo-skeletal systemWHO

Muscles, jointsand bones

87 medicines · 32 active substances · from the European Medicines Agency — Medicines output: medicines report

Browse the substances How this group is made

Counted from the register

The group in figures

  • 87products listed in the register
  • 0%without prescription (0)
  • 5combination products — more than one substance

What the group contains

Anatomical main group M of the WHO ATC classification: “Musculo-skeletal system”. US records carry no ATC code: a product is here because the FDA pharmacologic class on its record maps to this group — not because of any judgement about who it is for.

58 marketing authorisation holders

  • M05 61
  • M09 10
  • M04 7
  • M01 6
  • M03 3

ATC subgroups by code; their names are at the WHO index.

Source: European Medicines Agency — Medicines output: medicines report, 2026-09-30. Counts computed by Mediclarum from that file.

The most common
substances

DENOSUMABZOLEDRONIC ACIDIBANDRONIC ACID31108

never combined
in one product

Each number is how many products in the register contain that substance.

Active substances in this group

Commonest first, by number of products in the register. Select one to see every product that contains it.

  1. 01Denosumab31 productsprescription only
  2. 02Zoledronic acid10 productsprescription only
  3. 03Ibandronic acid8 productsprescription only
  4. 04Alendronic acid;colecalciferol3 productsprescription only
  5. 05Febuxostat3 productsprescription only
  6. 06Parecoxib3 productsprescription only
  7. 07Valdecoxib3 productsprescription only
  8. 08Eptotermin alfa2 productsprescription only
  9. 09Onasemnogene abeparvovec2 productsprescription only
  10. 10Strontium ranelate2 productsprescription only
  11. 11Allopurinol;lesinurad1 productprescription only
  12. 12Ataluren1 productprescription only
  13. 13Botulinum toxin type a1 productprescription only
  14. 14Botulinum toxin type B1 productprescription only
  15. 15Burosumab1 productprescription only
  16. 16Characterised viable autologous cartilage cells expanded ex vivo expressing specific marker proteins1 productprescription only
  17. 17Colchicine1 productprescription only
  18. 18Collagenase Clostridium histolyticum1 productprescription only
  19. 19Dantrolene sodium, hemiheptahydrate1 productprescription only
  20. 20Dibotermin alfa1 productprescription only
  21. 21Givinostat1 productprescription only
  22. 22Lesinurad1 productprescription only
  23. 23Matrix-applied characterised autologous cultured chondrocytes1 productprescription only
  24. 24Nusinersen1 productprescription only
  25. 25Pegloticase1 productprescription only
  26. 26Risdiplam1 productprescription only
  27. 27Romosozumab1 productprescription only
  28. 28Spheroids of human autologous matrix-associated chondrocytes1 productprescription only
  29. 29Vosoritide1 productprescription only
  30. 30Vysribli1 productprescription only

How this group is made

Each product is placed by the ATC code in its national register record (Bulgaria) or by the pharmacologic class the FDA assigned it (United States). Products without either are in no group rather than in a plausible one.

A group is not a diagnosis. Medicines are grouped by the class the regulator gave them. Which one suits you depends on things this page cannot know — ask a pharmacist or doctor.